This page shows the latest Phagenesis news and features for those working in and with pharma, biotech and healthcare.
These include Nestlé's $1.9bn partnership on potential inflammatory bowel disease treatments and the acquisition of UK medical device firm and dysphagia specialist Phagenesis..
Acquisition of UK's Phagenesis expected to be completed by 2019. Nestlé Health Science is continuing to expand its interests in the broader pharma space with the acquisition of UK medical ... The staged acquisition is expected to close in 2019 but
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Fishawack Health is the leading global commercialization partner for the modern life science era. Established in 2001 and headquartered in...